Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Anheuser-Busch InBev SA/NV
  6. News
  7. Summary
    ABI   BE0974293251

ANHEUSER-BUSCH INBEV SA/NV

(ABI)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-11-30 am EST
56.05 EUR   -0.27%
11/29China's BYD to sell EVs in Mexico next year, aims up to 30,000 sales in 2024
RE
11/28Anheuser Busch Inbev / : Form 6-K
PU
11/28AB INBEV : JP Morgan raises its recommendation from Sell to Buy
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

European ADRs Move Lower in Friday Trading

09/16/2022 | 11:07am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -0.91% 2.17 Delayed Quote.-43.73%
AKARI THERAPEUTICS, PLC 2.30% 0.5526 Delayed Quote.-63.99%
ANHEUSER-BUSCH INBEV SA/NV -0.27% 56.05 Real-time Quote.5.70%
AUTOLUS THERAPEUTICS PLC 5.18% 2.64 Delayed Quote.-51.64%
CRH PLC -0.77% 3292.5 Delayed Quote.-14.92%
EDAP TMS S.A. 0.62% 11.32 Delayed Quote.77.80%
ENDAVA PLC 8.39% 76.71 Delayed Quote.-57.85%
GRIFOLS, S.A. 2.12% 10.155 Delayed Quote.-41.07%
NOKIA OYJ 1.79% 4.653 Delayed Quote.-17.99%
PHILIPS NV 0.80% 14.192 Real-time Quote.-57.03%
PRUDENTIAL PLC 1.51% 979.4 Delayed Quote.-24.30%
SANOFI -1.94% 86.48 Real-time Quote.-0.44%
SPARK NETWORKS SE 6.42% 1.16 Delayed Quote.-65.29%
TRINITY BIOTECH PLC 0.00% 1.33 Delayed Quote.-6.99%
VERONA PHARMA PLC -0.08% 12.9 Delayed Quote.92.11%
ZEALAND PHARMA A/S 2.23% 201.4 Delayed Quote.35.77%
All news about ANHEUSER-BUSCH INBEV SA/NV
11/29China's BYD to sell EVs in Mexico next year, aims up to 30,000 sales in 2024
RE
11/28Anheuser Busch Inbev / : Form 6-K
PU
11/28AB INBEV : JP Morgan raises its recommendation from Sell to Buy
MD
11/23Fitch Affirms, Withdraws Rating On Belgian Brewery Group Anheuser-Busch InBev
MT
11/21AB INBEV : Jefferies sticks Neutral
MD
11/18FIFA Says Sales Alcoholic Beer Not Allowed at Qatar's World Cup Stadiums
MT
11/16Anheuser-Busch InBev SA/NV Launches Cash Tender Offers for up to USD 3.5 Billion Aggreg..
CI
11/16AB InBev Launches Tender Offer for $1.9 Billion of Notes due 2029, 2037
MT
11/04European ADRs Move Higher in Friday Trading
MT
10/31AB INBEV : Barclays reaffirms its Buy rating
MD
More news
Analyst Recommendations on ANHEUSER-BUSCH INBEV SA/NV
More recommendations
Financials (USD)
Sales 2022 58 497 M - -
Net income 2022 4 949 M - -
Net Debt 2022 69 063 M - -
P/E ratio 2022 22,7x
Yield 2022 1,04%
Capitalization 115 B 115 B -
EV / Sales 2022 3,14x
EV / Sales 2023 2,90x
Nbr of Employees 169 000
Free-Float 42,4%
Chart ANHEUSER-BUSCH INBEV SA/NV
Duration : Period :
Anheuser-Busch InBev SA/NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANHEUSER-BUSCH INBEV SA/NV
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 57,80 $
Average target price 65,04 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Michel Dimitrios Doukeris Chief Executive Officer & Director
Fernando Mommensohn Tennenbaum Chief Financial Officer
Martin J. Barrington Chairman
David Almeida Chief Strategy & Technology Officer
M. Michele Burns Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ANHEUSER-BUSCH INBEV SA/NV5.70%115 223
HEINEKEN N.V.-10.28%52 792
AMBEV S.A.1.95%46 928
CONSTELLATION BRANDS, INC.1.06%46 788
BUDWEISER BREWING COMPANY APAC LIMITED9.54%36 051
HEINEKEN HOLDING N.V.-10.66%21 593